Fundraising Fox
Nested Therapeutics
Founded 2021 · 16 employees on LinkedIn · 6 known investors
Find your way into Nested Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jeno Gyuris to introduce you to Philip Komarnitsky
You →Jeno · together at AVEO Oncology →Philip
Ask Jamie Chen to introduce you to Klaus Hoeflich
You →Jamie · together at Nested Therapeutics →Klaus
Sign up to find every way you can get introduced to Nested Therapeutics
- Your email: who you already know at Nested Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Nested Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.
Founders & leadership
Nested Therapeutics was founded in 2021 by Arvin Dar, Kevan Shokat, and Klaus Hoeflich.
Investors · 6
How we know: Versant Ventures's portfolio page · the company's own site · a partner's Signal profile · Not right? Tell us
How we know: Foresite Capital's portfolio page · press coverage · Not right? Tell us
How we know: Sixty Degree Capital's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseries AOct 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Nested Therapeutics do?
- Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.
- Who founded Nested Therapeutics?
- Nested Therapeutics was founded by Arvin Dar, Kevan Shokat, Klaus Hoeflich in 2021.
- Who are Nested Therapeutics's investors?
- Nested Therapeutics's investors include Versant Ventures, Foresite Capital, Sixty Degree Capital, Cowen Healthcare Investments, Goldman Sachs, Section 32.